Fareva Amboise

FDA inspection history across 2 sites, 2018 to 2026

2
Form 483s
1
Warning letter

Every document, by year

  • Warning letter
  • Form 483

2018: one Form 483; 2025: one Form 483; 2026: one warning letter.

The story so far

Built from the dates and citations on the documents themselves.

  1. 2018One Form 483, at Poce-sur-Cisse, France.
  2. 2025–26One Form 483 and one warning letter, at Poce Sur Cisse, France.
  3. 2025The longest 483 on file: 9 observations over 16 pages at Poce Sur Cisse, France.

Cited most

Across all Fareva Amboise observations on file

The complete Fareva Amboise file.

All 3 documents as original PDFs, in one order. For supplier audits, diligence and inspection prep.

$297

The price of the documents, added to your cart together

Sites

Also: one document not tied to a site.

Documents

3 on file, newest first
DateDocumentPrice
2026-04-10Warning letter Warning letter$99
2025-09-16483 Form 483$99
2018-05-25483 Form 483$99

FEI number 3000234005 · most recent document Apr 10, 2026

About Fareva Amboise

How many FDA Form 483s has Fareva Amboise received?

FDA Intel has 2 Form 483s on file for Fareva Amboise; the most recent is dated Sep 16, 2025.

When was Fareva Amboise last inspected by FDA?

The most recent FDA inspection document on file for Fareva Amboise is a Form 483 dated Sep 16, 2025, for the site in Poce Sur Cisse, France.

What did FDA cite at Fareva Amboise?

The regulations cited most in the observations on file for Fareva Amboise are 21 CFR 211.42(a) (Design and construction features), 3 times; 21 CFR 211.100(a) (Written procedures; deviations), 2 times; 21 CFR 211.113(b) (Control of microbiological contamination), 2 times.

Has Fareva Amboise received an FDA warning letter?

Yes. FDA Intel has 1 FDA warning letter on file for Fareva Amboise; the most recent is dated Apr 10, 2026.